Seikagaku Corporation (TYO:4548)

Market Cap	34.11B
Revenue (ttm)	39.37B
Net Income (ttm)	1.21B
Shares Out	54.58M
EPS (ttm)	22.25
PE Ratio	28.10
Forward PE	n/a
Dividend	30.00 (4.80%)
Ex-Dividend Date	Sep 29, 2025

Volume	313,100
Average Volume	155,540
Open	627.00
Previous Close	625.00
Day's Range	626.00 - 640.00
52-Week Range	603.00 - 899.00
Beta	0.25
RSI	48.65
Earnings Date	Aug 5, 2025

About Seikagaku

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, JOYCLU Gel-One, Hylink, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1947
• Employees: 1,075
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4548

Financial Performance

In 2024, Seikagaku's revenue was 39.37 billion, an increase of 8.73% compared to the previous year's 36.21 billion. Earnings were 1.21 billion, a decrease of -44.46%.